fda ind, page-53

If TT-034 works in humans, it (and ddRNAi) will be the biggest news story in medicine since the discovery of penicillin.

TT-034 has the ability, with a Global initiative, to eradicate HCV from existance within a generation. Something the competition simply cannot achieve.

I can't imagine that any BigPharma company would not want to be part of the biggest medical breakthrough in the last decade.